SanBio Company Limited (OTCMKTS:SNBIF) Short Interest Up 19.6% in February

SanBio Company Limited (OTCMKTS:SNBIF) was the recipient of a large growth in short interest in February. As of February 27th, there was short interest totaling 1,533,629 shares, a growth of 19.6% from the February 12th total of 1,282,295 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.

SanBio Price Performance

OTCMKTS SNBIF opened at C$10.11 on Wednesday. SanBio has a 52-week low of C$4.65 and a 52-week high of C$23.00. The business’s 50-day moving average price is C$10.11 and its 200 day moving average price is C$16.67.

Analyst Upgrades and Downgrades

Separately, UBS Group started coverage on shares of SanBio in a research note on Sunday, December 14th. They issued a “neutral” rating for the company. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company has an average rating of “Hold”.

About SanBio

SanBio Inc is a clinical‐stage regenerative medicine company focused on developing proprietary cell therapies to address central nervous system disorders. The company’s core technology is based on modulating the brain’s innate repair mechanisms through the transplantation of adult stem cells, with the goal of restoring neurological function in patients suffering from conditions such as stroke, traumatic brain injury and neurodegenerative diseases.

The company’s lead product candidate, SB623, is an investigational cell therapy for chronic motor deficits following ischemic stroke.